Jason Berndt

Translational Medicine - Late Stage Oncology Development

Seattle, Washington, United States

About

Experience

  • Director at Pfizer
    Jan 2024 - Present · 2 yrs 7 mos

  • Principal Scientist at Seagen
    Jun 2021 - Dec 2023 · 2 yrs 7 mos

  • Principal Scientist at PreCyte Inc
    Dec 2018 - May 2021 · 2 yrs 6 mos

  • Staff Scientist at Fred Hutch
    Aug 2017 - Nov 2018 · 1 yr 4 mos

    Laboratory of Jon Cooper Basic Sciences Division

  • Research Specialist II at Howard Hughes Medical Institute
    Mar 2015 - Aug 2017 · 2 yrs 6 mos